Literature DB >> 16690727

Very mild cases of Rett syndrome with skewed X inactivation.

P Huppke1, E M Maier, A Warnke, C Brendel, F Laccone, J Gärtner.   

Abstract

BACKGROUND: Rett syndrome, a common cause of mental retardation in females, is caused by mutations in the MECP2 gene. Most females with MECP2 mutations fulfil the established clinical criteria for Rett syndrome, but single cases of asymptomatic carriers have been described. It is therefore likely that there are individuals falling between these two extreme phenotypes.
OBJECTIVE: To describe three patients showing only minor symptoms of Rett syndrome.
FINDINGS: The patient with the best intellectual ability had predominantly psychiatric problems with episodes of uncontrolled aggression that have not been described previously in individuals with MECP2 mutations. All three patients had normal hand function, communicated well, and showed short spells of hyperventilation only under stress. Diagnosis in such individuals requires the identification of subtle signs of Rett syndrome in girls with a mild mental handicap. Analysis of the MECP2 gene revealed mutations that are often found in classical Rett syndrome. Skewed X inactivation was present in all three cases, which may explain the mild phenotype.
CONCLUSIONS: Because of skewed X inactivation, the phenotype of Rett patients may be very mild and hardly recognisable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690727      PMCID: PMC2563162          DOI: 10.1136/jmg.2006.042077

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28.

Authors:  N Sirianni; S Naidu; J Pereira; R F Pillotto; E P Hoffman
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

Review 2.  Rett syndrome: clinical peculiarities and biological mysteries.

Authors:  B Hagberg
Journal:  Acta Paediatr       Date:  1995-09       Impact factor: 2.299

3.  Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.

Authors:  P Huppke; F Laccone; N Krämer; W Engel; F Hanefeld
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

4.  Two affected boys in a Rett syndrome family: clinical and molecular findings.

Authors:  L Villard; A Kpebe; C Cardoso; P J Chelly; P M Tardieu; M Fontes
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

Review 5.  Molecular diagnosis of Rett syndrome.

Authors:  Peter Huppke; Jutta Gärtner
Journal:  J Child Neurol       Date:  2005-09       Impact factor: 1.987

6.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Authors:  J P Cheadle; H Gill; N Fleming; J Maynard; A Kerr; H Leonard; M Krawczak; D N Cooper; S Lynch; N Thomas; H Hughes; M Hulten; D Ravine; J R Sampson; A Clarke
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

7.  Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2.

Authors:  M D'Esposito; N A Quaderi; A Ciccodicola; P Bruni; T Esposito; M D'Urso; S D Brown
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

8.  X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.

Authors:  Daniel Braunschweig; Thomas Simcox; Rodney C Samaco; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

9.  X chromosome inactivation patterns in normal females.

Authors:  O Racchi; R Mangerini; D Rapezzi; M Rolfo; G F Gaetani; A M Ferraris
Journal:  Blood Cells Mol Dis       Date:  1998-12       Impact factor: 3.039

10.  Rett variants: a suggested model for inclusion criteria.

Authors:  B A Hagberg; O H Skjeldal
Journal:  Pediatr Neurol       Date:  1994-07       Impact factor: 3.372

View more
  21 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

Review 2.  Epigenetic and Cellular Diversity in the Brain through Allele-Specific Effects.

Authors:  Wei-Chao Huang; Kathleen Bennett; Christopher Gregg
Journal:  Trends Neurosci       Date:  2018-08-08       Impact factor: 13.837

3.  Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies.

Authors:  Rodney C Samaco; Christopher M McGraw; Christopher S Ward; Yaling Sun; Jeffrey L Neul; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2012-10-01       Impact factor: 6.150

Review 4.  Emerging pharmacotherapies for neurodevelopmental disorders.

Authors:  Daniel Z Wetmore; Craig C Garner
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

Review 5.  Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.

Authors:  Huda Y Zoghbi; Mark F Bear
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

6.  Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.

Authors:  Lieselot L G Carrette; Roy Blum; Weiyuan Ma; Raymond J Kelleher; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

7.  Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Hsiao-Tuan Chao; Christopher S Ward; Sharyl L Fyffe-Maricich; Jun Ren; Keith Hyland; Christina Thaller; Stephen M Maricich; Peter Humphreys; John J Greer; Alan Percy; Daniel G Glaze; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

8.  Diurnal variation in autonomic regulation among patients with genotyped Rett syndrome.

Authors:  Michael Sean Carroll; Jan-Marino Ramirez; Debra E Weese-Mayer
Journal:  J Med Genet       Date:  2020-03-10       Impact factor: 6.318

9.  MECP2 promoter methylation and X chromosome inactivation in autism.

Authors:  Raman P Nagarajan; Katherine A Patzel; Michelle Martin; Dag H Yasui; Susan E Swanberg; Irva Hertz-Picciotto; Robin L Hansen; Judy Van de Water; Isaac N Pessah; Ruby Jiang; Wendy P Robinson; Janine M LaSalle
Journal:  Autism Res       Date:  2008-06       Impact factor: 5.216

10.  Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.

Authors:  Alena Horská; Luciano Farage; Genila Bibat; Lídia M Nagae; Walter E Kaufmann; Peter B Barker; SakkuBai Naidu
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.